alpha(2)-plasmin inhibitor is a substrate for tissue transglutaminase: an in vitro study (Q33915670)

30 July 2017

title

alpha(2)-plasmin inhibitor is a substrate for tissue transglutaminase: an in vitro study (English)

1 reference

30 July 2017

Hevessy Z

1

1 reference

30 July 2017

Patthy A

series ordinal

2

1 reference

30 July 2017

Kárpáti L

series ordinal

3

1 reference

30 July 2017

Muszbek L

series ordinal

4

1 reference

30 July 2017

publication date

1 August 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

99

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

399-406

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900261-9

30 July 2017

1 reference

7 January 2021

Blood coagulation factor XIII: structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900261-9

7 January 2021

Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900261-9

7 January 2021

Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900261-9

7 January 2021

Tissue transglutaminase: an enzyme with a split personality

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900261-9

7 January 2021

Factors affecting gamma-chain multimer formation in cross-linked fibrin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900261-9

7 January 2021

Comparative studies on tissue transglutaminase and factor XIII

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900261-9

7 January 2021

Cross-linked A alpha.gamma chain hybrids serve as unique markers for fibrinogen polymerized by tissue transglutaminase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900261-9

7 January 2021

Cross-linking of α2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900261-9

7 January 2021

The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Application to the radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900261-9

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900261-9

7 January 2021

A filter paper assay for transamidating enzymes using radioactive amine substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900261-9

7 January 2021

Different N-terminal forms of alpha 2-plasmin inhibitor in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900261-9

7 January 2021

Bovine alpha 2-antiplasmin. N-terminal and reactive site sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900261-9

7 January 2021

Expression and characterization of pro alpha 2-plasmin inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900261-9

7 January 2021

Reversible cross-linking of alpha 2-plasmin inhibitor to fibrinogen by fibrin-stabilizing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900261-9

7 January 2021

Reaction of human alpha2-antiplasmin and plasmin stopped-flow fluorescence kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900261-9

7 January 2021

Characterization of recombinant human alpha 2-antiplasmin and of mutants obtained by site-directed mutagenesis of the reactive site

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900261-9

7 January 2021

Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900261-9

7 January 2021

Deposition of modified fibrinogen within the aortic intima

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2800%2900261-9

7 January 2021

10.1016/S0049-3848(00)00261-9

Identifiers

DOI

1 reference

30 July 2017

1 reference